Similar articles

• In vitro activity of tigecycline in combination with gentamicin against biofilm-forming Staphylococcus aureus.

  McConeghy KW, LaPlante KL. McConeghy KW, et al. Diagn Microbiol Infect Dis. 2010 Sep;68(1):1-6. doi: 10.1016/j.diagmicrobio.2010.04.011. Diagn Microbiol Infect Dis. 2010. PMID: 20727462
• In vitro activity of tigecycline against extended-spectrum β-lactamase-producing Enterobacteriaceae and MRSA clinical isolates from Mexico: a multicentric study.

  Silva-Sanchez J, Reyna-Flores F, Velazquez-Meza ME, Rojas-Moreno T, Benitez-Diaz A, Sanchez-Perez A; Study Group. Silva-Sanchez J, et al. Diagn Microbiol Infect Dis. 2011 Jun;70(2):270-3. doi: 10.1016/j.diagmicrobio.2010.12.018. Diagn Microbiol Infect Dis. 2011. PMID: 21596226
• Minocycline versus doxycycline for meticillin-resistant Staphylococcus aureus (MRSA): in vitro susceptibility versus in vivo effectiveness.

  Cunha BA. Cunha BA. Int J Antimicrob Agents. 2010 May;35(5):517-8. doi: 10.1016/j.ijantimicag.2010.01.017. Epub 2010 Mar 3. Int J Antimicrob Agents. 2010. PMID: 20202796 No abstract available.
• Methicillin-resistant Staphylococcus aureus: the superbug.

  Ippolito G, Leone S, Lauria FN, Nicastri E, Wenzel RP. Ippolito G, et al. Int J Infect Dis. 2010 Oct;14 Suppl 4:S7-11. doi: 10.1016/j.ijid.2010.05.003. Epub 2010 Sep 20. Int J Infect Dis. 2010. PMID: 20851011 Review.
• Minocycline--an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii.

  Bishburg E, Bishburg K. Bishburg E, et al. Int J Antimicrob Agents. 2009 Nov;34(5):395-401. doi: 10.1016/j.ijantimicag.2009.06.021. Epub 2009 Aug 8. Int J Antimicrob Agents. 2009. PMID: 19665876 Review.